| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.15B | 27.26B | 27.07B | 28.09B | 25.28B | 22.53B |
| Gross Profit | 11.96B | 12.14B | 12.32B | 12.88B | 11.79B | 10.57B |
| EBITDA | 2.92B | 3.67B | 4.00B | 5.22B | 4.45B | 3.78B |
| Net Income | 547.00M | 1.35B | 1.84B | 2.49B | 1.86B | 1.55B |
Balance Sheet | ||||||
| Total Assets | 65.62B | 67.57B | 65.99B | 67.26B | 64.79B | 61.72B |
| Cash, Cash Equivalents and Short-Term Investments | 13.67B | 20.30B | 25.16B | 31.82B | 31.80B | 31.20B |
| Total Debt | 1.63B | 1.59B | 1.63B | 1.75B | 1.74B | 1.16B |
| Total Liabilities | 8.49B | 9.38B | 8.82B | 9.49B | 9.12B | 7.22B |
| Stockholders Equity | 57.12B | 58.17B | 57.16B | 57.76B | 55.66B | 54.49B |
Cash Flow | ||||||
| Free Cash Flow | -1.54B | -2.08B | -3.61B | 1.24B | 1.73B | 2.11B |
| Operating Cash Flow | 554.00M | 2.71B | 2.31B | 2.30B | 2.95B | 3.76B |
| Investing Cash Flow | -2.53B | -6.85B | -333.00M | 4.65B | 3.64B | -6.12B |
| Financing Cash Flow | -423.50M | -1.39B | -3.74B | -1.50B | -1.15B | -1.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥70.23B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥65.86B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
72 Outperform | ¥178.75B | 14.12 | 10.28% | 2.77% | 2.74% | 7.86% | |
70 Outperform | ¥166.55B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥88.33B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥31.44B | 4.17 | ― | 2.13% | 1.13% | -66.14% |